Last updated 2026-06-18
- Acquired by Kalytera Therapeutics, Feb 2017
Total raised
—
Stage
Acquired
Founded
2014
Headcount
6
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences
About
TALENT Biotechs develops cannabidiol-based therapies.TALENT screens and locates pharmaceutical and medical technologies patented in the global market and leverages the development process of research and clinical trials throughPhase II into a Phase IIIstarting point. TALENThas suggestedthe use of cannabidiol for the prevention and treatment of graft-versus-host disease, which is a major cause of morbidity and mortality withallogeneic hematopoietic stem cell transplantation. TALENT Biotechs has been acquired by Kalytera Therapeutics, Beverly, Massachusetts, United States.
Q&A
- What is TALENT Biotechs' primary focus?
- TALENT Biotechs develops cannabidiol-based therapies, specifically screening for and leveraging patented pharmaceutical and medical technologies through clinical trials.
- When was TALENT Biotechs founded?
- TALENT Biotechs was founded in January 2014.
- What is the current status of TALENT Biotechs?
- TALENT Biotechs was acquired by Kalytera Therapeutics in February 2017 and is currently inactive.
- Who acquired TALENT Biotechs?
- TALENT Biotechs was acquired by Kalytera Therapeutics, based in Beverly, Massachusetts, United States.
- What specific medical condition did TALENT Biotechs suggest cannabidiol for?
- TALENT Biotechs suggested the use of cannabidiol for the prevention and treatment of graft-versus-host disease.
- How many employees did TALENT Biotechs have at the time of its acquisition?
- TALENT Biotechs had 1-10 employees.
- Who is the founder of TALENT Biotechs?
- Moshe Yeshurun is the founder of TALENT Biotechs.
- In which sector does TALENT Biotechs primarily operate?
- TALENT Biotechs operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Medical Cannabis.
Team · 1
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalscannabisoncologypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2014-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired (Inactive) by Kalytera Therapeutics on Feb 2017 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Kalytera Therapeutics 2017-02